Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Mesothelin Targeting Bites for Pediatric AML: In Vivo Efficacy and Specificity

Anilkumar Gopalakrishnapillai, PhD, Colin Correnti, PhD, Anne Kisielewski, BS, Allison Kaeding, MD, Soheil Meshinchi, MD PhD, E. Anders Kolb, MD, Sonali Barwe, PhD MSc

Blood (2019) 134 (Supplement_1): 3925.

https://doi.org/10.1182/blood-2019-130941

Published: 2019

Journal Articles

Chimeric Antigen Receptor T Cell Therapy Pipeline at a Glance: A Retrospective and Systematic Analysis from Clinicaltrials.Gov

Eider F Moreno Cortes, MD, Caleb K Stein, PhD, Paula A Lengerke Diaz, MD, Cesar A Ramirez-Segura, BS, PhD, Januario E. Castro, MD

Blood (2019) 134 (Supplement_1): 5629.

https://doi.org/10.1182/blood-2019-132273

Published: 2019

Journal Articles

In Vivo Evaluation of Mesothelin As a Therapeutic Target in Pediatric Acute Myeloid Leukemia

Anilkumar Gopalakrishnapillai, PhD, Allison Kaeding, MD, Christoph Schatz, PhD, Anette Sommer, PhD, Soheil Meshinchi, MD PhD, E. Anders Kolb, MD, Sonali Barwe, PhD MSc

Blood (2019) 134 (Supplement_1): 1370.

https://doi.org/10.1182/blood-2019-123794

Published: 2019

Journal Articles

Enhancing Human NK Cell Function and Specificity for Cancer Immunotherapy

Pomeroy Emily, Hunzeker John, Kluesner Mitchell, Crosby Margaret, Laura Bendzick, Jeffrey S. Miller, MD, Beau Webber, PhD, Melissa A. Geller, Martin Felices, PhD, Tim Starr, Branden S Moriarity, PhD

Blood (2018) 132 (Supplement 1): 2044.

https://doi.org/10.1182/blood-2018-99-120173

Published: 2018

Journal Articles

Optimized FVIII-Domain-Based Chimeric Antigen Receptors to Specifically Target FVIII Inhibitor-Producing B Cells in Hemophilia a

Vijay Bhoj, MD PhD, Lucy Li, Benjamin J. Samelson-Jones, MD PhD, Bhavya S Doshi, MD, Christoph Ellebrecht, MD, Aimee Payne, MD PhD, Valder R Arruda, MD PhD, Michael C. Milone, MD PhD

Blood (2018) 132 (Supplement 1): 2196.

https://doi.org/10.1182/blood-2018-99-120031

Published: 2018

Journal Articles

Mesothelin Is a Novel Disease Marker and Potential Therapeutic Target in Pediatric Acute Myeloid Leukemia

Allison Kaeding, MD, Katherine Tarlock, MD, Sonali Barwe, PhD, Anilkumar Gopalakrisnapillai, PhD, Todd A Alonzo, PhD, Robert B Gerbing, Michael R. Loken, PhD, Rhonda E. Ries, MA, Laura Pardo, Cassie Chou, MD PhD, E. Anders Kolb, MD, Soheil Meshinchi, MD PhD

Blood (2017) 130 (Supplement 1): 2641.

https://doi.org/10.1182/blood.V130.Suppl_1.2641.2641

Published: 2017

Journal Articles

Engineering Human Induced Pluripotent Stem Cells with Novel Chimeric Antigen Receptors to Generate Natural Killer (NK) Cell Cancer Immunotherapies with Targeted Anti-Tumor Activity

Ye Ethan Ethan Li, MD, David Hermanson, PhD, Branden Moriarity, PhD, Ryan Bjordahl, PhD, Sajid Mahmood, PhD, Bahram Valamehr, PhD, Dan Kaufman, MD

Blood (2017) 130 (Supplement 1): 1905.

https://doi.org/10.1182/blood.V130.Suppl_1.1905.1905

Published: 2017

Journal Articles

Altered Transcriptome Uniquely Associated with AML Vs. Normal Hematopoiesis

Yu Fan, Ying Hu, Cu Nguyen, Chunhua Yan, Rhonda E. Ries, MA, Hamid Bolouri, PhD, Jenny L. Smith, MSc, MD, Qingrong Chen, E. Anders Kolb, MD, Soheil Meshinchi, MD PhD, Daoud Meerzaman

Blood (2017) 130 (Supplement 1): 3792.

https://doi.org/10.1182/blood.V130.Suppl_1.3792.3792

Published: 2017

Journal Articles

Toll-like Receptor 2 Costimulation Potentiates the Antitumor Efficacy of CAR T Cells

Peng Li, PhD, Xin Du, Yunxin Lai, PhD, Jianyu Weng, Qin Le, Yangqiu Li

Blood (2017) 130 (Supplement 1): 5046.

https://doi.org/10.1182/blood.V130.Suppl_1.5046.5046

Published: 2017

Journal Articles

Discovery and Validation of Cell-Surface Protein Mesothelin (MSLN) As a Novel Therapeutic Target in AML: Results from the COG/NCI Target AML Initiative

Blood (2016) 128 (22): 2873.

https://doi.org/10.1182/blood.V128.22.2873.2873

Published: 2016

Journal Articles

Oncolytic Adenovirus Expressing Cytokines Enhances Anti-Tumor Efficacy of Mesothelin-Redirected CAR-T Cells

Keisuke Watanabe, MD PhD, Sonia Guedan, PhD, John Scholler, Shannon McGettigan, Yangpin Luo, Siri Tähtinen, Suvi Parviainen, PhD, Riikka Havunen, Mikko Siurala, Akseli Hemminki, MD PhD, Carl H June, MD

Blood (2016) 128 (22): 3360.

https://doi.org/10.1182/blood.V128.22.3360.3360

Published: 2016

Journal Articles

Transition of Chronic Myeloid Leukemia to Chronic Myelomonocytic Leukemia As a Tool to Observe Development of Chronic Myelomonocytic Leukemia

Jamshid S Khorashad, MD PhD, Srinivas K Tantravahi, Dongqing Yan, PhD, Anna M. Eiring, PhD, Hannah M. Redwine, Amber D. Bowler, Kevin C. Gantz, Keith M Gligorich, PhD, Anthony D Pomicter, MS, Todd W Kelley, MD, Thomas O'Hare, PhD, Michael W Deininger, MD PhD

Blood (2015) 126 (23): 5223.

https://doi.org/10.1182/blood.V126.23.5223.5223

Published: 2015

Journal Articles

Multigene MRD Assessment Improves AML Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation

Matthew P. Mulé, BS, Gabriel N. Mannis, MD, Jerald P. Radich, MD, Brent L. Wood, MDPhD, Nestor R. Ramos, MD, Catherine E. Lai, MD, Michael Flanders, BA, Charalambos Andreadis, MD MSCE, Lloyd E. Damon, MD, Aaron C. Logan, MDPhD, Thomas G. Martin, MD, Christopher S. Hourigan, MDPhD

Blood (2015) 126 (23): 4350.

https://doi.org/10.1182/blood.V126.23.4350.4350

Published: 2015

Journal Articles

A Novel Multi-Gene Array Allows Relapse Risk Stratification in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation

Meghali Goswami, BS, Katherine S. McGowan, Kit Lu, MD, Natasha A Jain, MD, Julián Candia, PhD, Nancy F. Hensel, Jingrong Tang, MDPhD, Katherine R. Calvo, MD, PhD, Minoo Battiwalla, MDMS, Austin John Barrett, MDFRCP,FRCPath, Christopher S. Hourigan, MDPhD

Blood (2014) 124 (21): 667.

https://doi.org/10.1182/blood.V124.21.667.667

Published: 2014

Journal Articles

Signaling Domain of Chimeric Antigen Receptors Can Reprogram T Cells

Omkar Uday Kawalekar, MS, BS, Roddy O'Connor, PhD, Sonia Guedan, PhD, Joseph Fraietta, PhD, Avery D. Posey, PhD, John Scholler, Michael C Milone, MD PhD, Carl H. June, MD

Blood (2014) 124 (21): 551.

https://doi.org/10.1182/blood.V124.21.551.551

Published: 2014

Journal Articles

Distinct Signaling By Chimeric Antigen Receptors (CARs) Containing CD28 Signaling Domain Versus 4-1BB In Primary Human T Cells

Omkar Uday Kawalekar, MS, BS, Avery D. Posey, Jr., Joseph Fraietta, Jihyun Lee, John Scholler, Yangbing Zhao, Carl H. June, MD

Blood (2013) 122 (21): 2902.

https://doi.org/10.1182/blood.V122.21.2902.2902

Published: 2013

Journal Articles

Functional Chimeric Antigen Receptor-Expressing Natural Killer Cells Derived From Human Pluripotent Stem Cells

David L Hermanson, PhD, Zhenya Ni, DVM/PhD, David A. Knorr, PhD, Laura Bendzick, BS, Lee J Pribyl, BS, Melissa Geller, MD, Dan S. Kaufman, M.D., Ph.D.

Blood (2013) 122 (21): 896.

https://doi.org/10.1182/blood.V122.21.896.896

Published: 2013

Journal Articles

Whole-Genome Sequencing Results From 30 Patients with Waldenstrom's Macroglobulinemia

Zachary Hunter, Lian Xu, Yangsheng Zhou, MD, Guang Yang, PhD, Xia Liu, MD, Yang Cao, MD, Christina Hanzis, Patricia Sheehy, NP, Robert Manning, Christopher J Patterson, Jason M Laramie, PhD, Donald A Skifter, PhD, Stephen E Lincoln, PhD, Steven P Treon, MD, PhD

Blood (2011) 118 (21): 434.

https://doi.org/10.1182/blood.V118.21.434.434

Published: 2011

Journal Articles

Identification of a Set of Seven Genes for the Monitoring of Minimal Residual Disease in Pediatric Acute Myeloid Leukemia.

Daniel Steinbach, MD, Alexander Schramm, PhD, Angelika Eggert, MD, Susann Wittig, Nadine Pfaffendorf, Astrid Voigt, PhD, Felix Zintl, MD, Bernd Gruhn, MD

Blood (2005) 106 (11): 1461.

https://doi.org/10.1182/blood.V106.11.1461.1461

Published: 2005

NARROW

Mesothelin Targeting Bites for Pediatric AML: In Vivo Efficacy and Specificity

Chimeric Antigen Receptor T Cell Therapy Pipeline at a Glance: A Retrospective and Systematic Analysis from Clinicaltrials.Gov

In Vivo Evaluation of Mesothelin As a Therapeutic Target in Pediatric Acute Myeloid Leukemia

Enhancing Human NK Cell Function and Specificity for Cancer Immunotherapy

Optimized FVIII-Domain-Based Chimeric Antigen Receptors to Specifically Target FVIII Inhibitor-Producing B Cells in Hemophilia a

Mesothelin Is a Novel Disease Marker and Potential Therapeutic Target in Pediatric Acute Myeloid Leukemia

Engineering Human Induced Pluripotent Stem Cells with Novel Chimeric Antigen Receptors to Generate Natural Killer (NK) Cell Cancer Immunotherapies with Targeted Anti-Tumor Activity

Altered Transcriptome Uniquely Associated with AML Vs. Normal Hematopoiesis

Toll-like Receptor 2 Costimulation Potentiates the Antitumor Efficacy of CAR T Cells

Discovery and Validation of Cell-Surface Protein Mesothelin (MSLN) As a Novel Therapeutic Target in AML: Results from the COG/NCI Target AML Initiative

Oncolytic Adenovirus Expressing Cytokines Enhances Anti-Tumor Efficacy of Mesothelin-Redirected CAR-T Cells

Transition of Chronic Myeloid Leukemia to Chronic Myelomonocytic Leukemia As a Tool to Observe Development of Chronic Myelomonocytic Leukemia

Multigene MRD Assessment Improves AML Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation

A Novel Multi-Gene Array Allows Relapse Risk Stratification in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation

Signaling Domain of Chimeric Antigen Receptors Can Reprogram T Cells

Distinct Signaling By Chimeric Antigen Receptors (CARs) Containing CD28 Signaling Domain Versus 4-1BB In Primary Human T Cells

Functional Chimeric Antigen Receptor-Expressing Natural Killer Cells Derived From Human Pluripotent Stem Cells

Whole-Genome Sequencing Results From 30 Patients with Waldenstrom's Macroglobulinemia

Identification of a Set of Seven Genes for the Monitoring of Minimal Residual Disease in Pediatric Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only